Page last updated: 2024-12-07

phlorofucofuroeckol a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

phlorofucofuroeckol A: phlorotannin from Ecklonia kurome; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID130976
CHEMBL ID510508
SCHEMBL ID2230693
MeSH IDM0176694

Synonyms (14)

Synonym
4,9-bis(3,5-dihydroxyphenoxy)benzofuro[3,2-a]oxanthrene-1,3,6,10,12-pentol
5,8,13-trioxaindeno[1,2-a]anthracene-1,3,6,10,12-pentol, 4,9-bis(3,5-dihydroxyphenoxy)-
phlorofucofuroeckol a
phlorofucofuroeckol-a
4,9-bis(3,5-dihydroxyphenoxy)benzofuro[3,2-a]dibenzo[b,e][1,4]dioxine-1,3,6,10,12-pentaol
bdbm50276756
CHEMBL510508 ,
4,9-bis(3,5-dihydroxyphenoxy)-[1]benzofuro[3,2-a]oxanthrene-1,3,6,10,12-pentol
128129-56-6
1,11-di-(3,5-dihydroxyphenoxy)benzofuro(3,2-a)dibenzo(b,e)(1,4)-dioxin-2,4,8,10,14-pentaol
benzo(b)benzofuro(3,2-f)(1,4)benzodioxin-1,3,6,10,12-pentol, 4,9-bis(3,5-dihydroxyphenoxy)-
SCHEMBL2230693
DTXSID40155821
Q7186528

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Pre-treatment of phlorofucofuroeckol A attenuated the productions of nitric oxide, prostaglandin E2, and pro-inflammatory cytokines in LPS-stimulated microglia."( Phlorofucofuroeckol A suppresses expression of inducible nitric oxide synthase, cyclooxygenase-2, and pro-inflammatory cytokines via inhibition of nuclear factor-κB, c-Jun NH2-terminal kinases, and Akt in microglial cells.
Choi, JW; Jang, BC; Kim, AR; Kim, HR; Kim, JI; Lee, MS; Utsuki, T, 2013
)
2.16
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirusIC50 (µMol)95.65000.00402.92669.9600AID753301; AID753310
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirusKi10.60000.00753.00839.1100AID753309
Beta-secretase 1Homo sapiens (human)IC50 (µMol)2.13000.00061.619410.0000AID483707
Beta-secretase 1Homo sapiens (human)Ki1.30000.00031.35248.0000AID483708
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (17)

Processvia Protein(s)Taxonomy
symbiont-mediated perturbation of host ubiquitin-like protein modificationReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
proteolysisBeta-secretase 1Homo sapiens (human)
membrane protein ectodomain proteolysisBeta-secretase 1Homo sapiens (human)
response to lead ionBeta-secretase 1Homo sapiens (human)
protein processingBeta-secretase 1Homo sapiens (human)
amyloid-beta formationBeta-secretase 1Homo sapiens (human)
amyloid precursor protein catabolic processBeta-secretase 1Homo sapiens (human)
positive regulation of neuron apoptotic processBeta-secretase 1Homo sapiens (human)
amyloid-beta metabolic processBeta-secretase 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painBeta-secretase 1Homo sapiens (human)
prepulse inhibitionBeta-secretase 1Homo sapiens (human)
cellular response to copper ionBeta-secretase 1Homo sapiens (human)
cellular response to manganese ionBeta-secretase 1Homo sapiens (human)
presynaptic modulation of chemical synaptic transmissionBeta-secretase 1Homo sapiens (human)
signaling receptor ligand precursor processingBeta-secretase 1Homo sapiens (human)
cellular response to amyloid-betaBeta-secretase 1Homo sapiens (human)
amyloid fibril formationBeta-secretase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (16)

Processvia Protein(s)Taxonomy
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
K63-linked deubiquitinase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
K48-linked deubiquitinase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
amyloid-beta bindingBeta-secretase 1Homo sapiens (human)
endopeptidase activityBeta-secretase 1Homo sapiens (human)
aspartic-type endopeptidase activityBeta-secretase 1Homo sapiens (human)
protein bindingBeta-secretase 1Homo sapiens (human)
peptidase activityBeta-secretase 1Homo sapiens (human)
beta-aspartyl-peptidase activityBeta-secretase 1Homo sapiens (human)
enzyme bindingBeta-secretase 1Homo sapiens (human)
protein serine/threonine kinase bindingBeta-secretase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (21)

Processvia Protein(s)Taxonomy
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
lysosomeBeta-secretase 1Homo sapiens (human)
endosomeBeta-secretase 1Homo sapiens (human)
early endosomeBeta-secretase 1Homo sapiens (human)
late endosomeBeta-secretase 1Homo sapiens (human)
multivesicular bodyBeta-secretase 1Homo sapiens (human)
endoplasmic reticulum lumenBeta-secretase 1Homo sapiens (human)
Golgi apparatusBeta-secretase 1Homo sapiens (human)
trans-Golgi networkBeta-secretase 1Homo sapiens (human)
plasma membraneBeta-secretase 1Homo sapiens (human)
synaptic vesicleBeta-secretase 1Homo sapiens (human)
cell surfaceBeta-secretase 1Homo sapiens (human)
endosome membraneBeta-secretase 1Homo sapiens (human)
membraneBeta-secretase 1Homo sapiens (human)
axonBeta-secretase 1Homo sapiens (human)
dendriteBeta-secretase 1Homo sapiens (human)
neuronal cell bodyBeta-secretase 1Homo sapiens (human)
membrane raftBeta-secretase 1Homo sapiens (human)
recycling endosomeBeta-secretase 1Homo sapiens (human)
Golgi-associated vesicle lumenBeta-secretase 1Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseBeta-secretase 1Homo sapiens (human)
endosomeBeta-secretase 1Homo sapiens (human)
plasma membraneBeta-secretase 1Homo sapiens (human)
trans-Golgi networkBeta-secretase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (24)

Assay IDTitleYearJournalArticle
AID393270Antioxidant activity assessed as Fenton system generated hydroxyl radical scavenging activity by ESR spectrometer2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID393272Antioxidant activity assessed as superoxide radical scavenging activity2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID753304Selectivity index, ratio of CC50 for african green monkey Vero cells to IC50 for SARS coronavirus 3C-like protease cis-cleavage activity transfected in african green monkey Vero cells2013Bioorganic & medicinal chemistry, Jul-01, Volume: 21, Issue:13
Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava.
AID393273Antioxidant activity assessed as APPH generated peroxyl radical scavenging formation by ESR spectrometer2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID483708Noncompetitive inhibition of human recombinant BACE1 after 60 mins by Dixon plot analysis2010Bioorganic & medicinal chemistry letters, Jun-01, Volume: 20, Issue:11
Molecular docking studies of phlorotannins from Eisenia bicyclis with BACE1 inhibitory activity.
AID427081Inhibition of Fc-epsilonR1-mediated histamine release in anti-human Fc-epsilonR1 antibody-stimulated human KU-812F cells by spectrofluorimetry2009Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13
Inhibitory effects of phloroglucinol derivatives isolated from Ecklonia stolonifera on Fc(epsilon)RI expression.
AID483707Inhibition of human recombinant BACE1 after 60 mins by FRET assay2010Bioorganic & medicinal chemistry letters, Jun-01, Volume: 20, Issue:11
Molecular docking studies of phlorotannins from Eisenia bicyclis with BACE1 inhibitory activity.
AID753301Inhibition of SARS coronavirus 3C-like protease cis-cleavage activity transfected in african green monkey Vero cells using SAVLQSGFRK as substrate after 5 hrs by luciferase reporter gene assay2013Bioorganic & medicinal chemistry, Jul-01, Volume: 21, Issue:13
Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava.
AID393282Inhibition of Fe(2+)/H2O2-generated hydroxyl radical induced membrane protein oxidation in mouse RAW264.7 cells at 1 uM to 50 uM relative to control2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID427078Inhibition of Fc-epsilonR1 protein expression in anti-human Fc-epsilonR1 antibody-stimulated human KU-812F cells after 24 hrs by Western blotting2009Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13
Inhibitory effects of phloroglucinol derivatives isolated from Ecklonia stolonifera on Fc(epsilon)RI expression.
AID753298Competitive inhibition of C-terminal His6-tagged recombinant SARS coronavirus 3C-like protease trans-cleavage activity expressed in Escherichia coli BL21 (DE3) using Dabcyl-KTSAVLQSGFRKME as substrate after 60 mins by Lineweaver-Burk plot analysis2013Bioorganic & medicinal chemistry, Jul-01, Volume: 21, Issue:13
Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava.
AID1704263Inhibition of SARS-CoV-2 3c-like protease2020European journal of medicinal chemistry, Nov-15, Volume: 206The development of Coronavirus 3C-Like protease (3CL
AID393277Antioxidant activity against mouse RAW264.7 cells assessed as reduction of ROS production measured by fluorescent dichlorofluorescein using DCFH-DA substrate2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID393278Antioxidant activity against mouse RAW264.7 cells assessed as reduction of ROS production after 200 mins measured by fluorescent dichlorofluorescein using DCFH-DA substrate2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID427082Cytotoxicity against human KU-812F cells assessed as reduction in cell viability at 1 to 50 uM after 24 hrs by MTS assay2009Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13
Inhibitory effects of phloroglucinol derivatives isolated from Ecklonia stolonifera on Fc(epsilon)RI expression.
AID393275Cytotoxicity against mouse RAW264.7 cells at 100 uM after 24 hrs by MTT assay2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID753310Inhibition of C-terminal His6-tagged recombinant SARS coronavirus 3C-like protease trans-cleavage activity expressed in Escherichia coli BL21 (DE3) using Dabcyl-KTSAVLQSGFRKME as substrate after 60 mins by FRET assay2013Bioorganic & medicinal chemistry, Jul-01, Volume: 21, Issue:13
Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava.
AID753302Cytotoxicity against african green monkey Vero cells assessed as cell death by MTT assay2013Bioorganic & medicinal chemistry, Jul-01, Volume: 21, Issue:13
Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava.
AID393276Cytotoxicity against human HL60 cells at 100 uM after 24 hrs by MTT assay2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID427080Inhibition of Fc-epsilonR1-mediated [Ca2+]i elevation in anti-human Fc-epsilonR1 antibody-stimulated human KU-812F cells2009Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13
Inhibitory effects of phloroglucinol derivatives isolated from Ecklonia stolonifera on Fc(epsilon)RI expression.
AID393274Cytotoxicity against human MRC5 cells at 100 uM after 24 hrs by MTT assay2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID427079Inhibition of Fc-epsilonR1 alpha mRNA expression in anti-human Fc-epsilonR1 antibody-stimulated human KU-812F cells after 24 hrs by RT-PCR2009Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13
Inhibitory effects of phloroglucinol derivatives isolated from Ecklonia stolonifera on Fc(epsilon)RI expression.
AID393271Antioxidant activity assessed as DPPH radical scavenging activity2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID753309Competitive inhibition of C-terminal His6-tagged recombinant SARS coronavirus 3C-like protease trans-cleavage activity expressed in Escherichia coli BL21 (DE3) using Dabcyl-KTSAVLQSGFRKME as substrate after 60 mins by Dixon plot analysis2013Bioorganic & medicinal chemistry, Jul-01, Volume: 21, Issue:13
Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (3.33)18.2507
2000's5 (16.67)29.6817
2010's19 (63.33)24.3611
2020's5 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.62 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index5.43 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other29 (96.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]